Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.
The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...
Pharmaceutical Technology on MSN
JPM26: Illumina debuts billion cell atlas to drive AI-driven drug discovery
The Billion Cell Atlas, backed by Eli Lilly, MSD and AstraZeneca, maps mechanisms to support informed drug discovery.
News-Medical.Net on MSN
Immune cell atlas may improve survival predictions, guide treatment decisions in multiple myeloma
aps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback